<description>&lt;p&gt;Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.&lt;/p&gt;&lt;p&gt;NCPD information and select publications &lt;a href="https://www.researchtopractice.com/ONU2024/BispecificsMM" rel="noopener noreferrer" target="_blank"&gt;here&lt;/a&gt;. &lt;/p&gt;</description>

Oncology Today with Dr Neil Love

Research To Practice

Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology Nurses

MAR 24, 202565 MIN
Oncology Today with Dr Neil Love

Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology Nurses

MAR 24, 202565 MIN

Description

Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.

NCPD information and select publications here.